BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferraù F, Ceccato F, Cannavò S, Scaroni C. What we have to know about corticosteroids use during Sars-Cov-2 infection. J Endocrinol Invest 2021;44:693-701. [PMID: 32860209 DOI: 10.1007/s40618-020-01384-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Cattaneo D, Pasina L, Conti F, Giacomelli A, Oreni L, Pezzati L, Bonazzetti C, Piscaglia M, Carrozzo G, Antinori S, Gervasoni C. Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience. J Endocrinol Invest 2021. [PMID: 34053008 DOI: 10.1007/s40618-021-01604-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Lam C, Siefkas A, Zelin NS, Barnes G, Dellinger RP, Vincent JL, Braden G, Burdick H, Hoffman J, Calvert J, Mao Q, Das R. Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids. Clin Ther 2021:S0149-2918(21)00128-4. [PMID: 33865643 DOI: 10.1016/j.clinthera.2021.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ceccato F, Voltan G, Sabbadin C, Camozzi V, Merante Boschin I, Mian C, Zanotto V, Donato D, Bordignon G, Capizzi A, Carretta G, Scaroni C. Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period. J Endocrinol Invest 2021;44:1689-98. [PMID: 33355915 DOI: 10.1007/s40618-020-01476-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
4 Bartolomucci A, Sapolsky RM. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19. Biol Psychiatry 2021;89:e67-71. [PMID: 33487440 DOI: 10.1016/j.biopsych.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Lin S, Lau LH, Chanchlani N, Kennedy NA, Ng SC. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic. Gut 2022;71:1426-39. [PMID: 35477864 DOI: 10.1136/gutjnl-2021-326784] [Reference Citation Analysis]
6 Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW. Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab 2021;4:e00246. [PMID: 34268454 DOI: 10.1002/edm2.246] [Reference Citation Analysis]
7 Sabbadin C, Betterle C, Scaroni C, Ceccato F. Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19. Front Endocrinol (Lausanne) 2021;12:805647. [PMID: 35002978 DOI: 10.3389/fendo.2021.805647] [Reference Citation Analysis]
8 Abdel-Moneim A, Hosni A. Insights into the possible impact of COVID-19 on the endocrine system. Arch Physiol Biochem 2021;:1-9. [PMID: 33653188 DOI: 10.1080/13813455.2021.1890131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mifsud S, Gauci Z, Gruppetta M, Mallia Azzopardi C, Fava S. Adrenal insufficiency in HIV/AIDS: a review. Expert Rev Endocrinol Metab 2021;:1-12. [PMID: 34521306 DOI: 10.1080/17446651.2021.1979393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fleseriu M. Pituitary Disorders and COVID-19, Reimagining Care: The Pandemic A Year and Counting. Front Endocrinol (Lausanne) 2021;12:656025. [PMID: 33776943 DOI: 10.3389/fendo.2021.656025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sieber P, Flury D, Güsewell S, Albrich WC, Boggian K, Gardiol C, Schlegel M, Sieber R, Vernazza P, Kohler P. Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study. BMC Infect Dis 2021;21:271. [PMID: 33731019 DOI: 10.1186/s12879-021-05957-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jensterle M, Herman R, Janež A, Mahmeed WA, Al-rasadi K, Al-alawi K, Banach M, Banerjee Y, Ceriello A, Cesur M, Cosentino F, Galia M, Goh S, Kalra S, Kempler P, Lessan N, Lotufo P, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Viswanathan V, Rizzo M. The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel. IJMS 2022;23:7326. [DOI: 10.3390/ijms23137326] [Reference Citation Analysis]
13 Cattaneo D, Pasina L, Maggioni AP, Giacomelli A, Oreni L, Covizzi A, Bradanini L, Schiuma M, Antinori S, Ridolfo A, Gervasoni C. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging 2020;37:925-33. [PMID: 33150470 DOI: 10.1007/s40266-020-00812-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lariccia V, Magi S, Serfilippi T, Toujani M, Gratteri S, Amoroso S. Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review. J Clin Med 2020;9:E4021. [PMID: 33322733 DOI: 10.3390/jcm9124021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kocherlakota C, Nagaraju B, Arjun N, Srinath A, Kothapalli KSD, Brenna JT. Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute lung inflammation in rats: Implications for treatment of COPD and COVID-19. Prostaglandins Leukot Essent Fatty Acids 2022;179:102426. [PMID: 35381532 DOI: 10.1016/j.plefa.2022.102426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]